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ABSTRACT  
 
Aims: To assess the inter-observer reproducibility of individual Gleason grade 4 growth 
patterns.  
Methods: Twenty-three genitourinary pathologists participated in the evaluation of 60 
selected high-magnification photographs. The selection included 10 cases of Gleason 
grade 3, 40 Gleason grade 4 (10 per growth pattern) and 10 Gleason grade 5. 
Participants were asked to select a single predominant Gleason grade per case (3, 4, 5) 
and to indicate the predominant Gleason grade 4 growth pattern if present. “Consensus” 
was defined as at least 80% agreement and “favoured” as 60-80% agreement. 
Results: Consensus on Gleason grading was reached in 47/60 (78%) cases, 35 of which 
were assigned a grade 4. In the 13 non-consensus cases, ill-formed (6/13, 46%) and 
fused (7/13, 54%) patterns were involved in disagreement. Among the 20 cases where 
at least 1 pathologist assigned the ill-formed growth pattern none (0%, 0/20) reached 
consensus. Consensus for fused, cribriform and glomeruloid glands was reached in 2%, 
23%, and 38%, respectively. In 9/35 (26%) consensus Gleason grade 4 cases, 
participants disagreed on growth pattern. Six of these were characterized by large 
epithelial proliferations with delicate intervening fibro-vascular cores, which were 
alternately given fused or cribriform growth pattern (“complex fused”).  
Conclusions: Consensus on Gleason grade 4 growth pattern was predominantly 
reached on cribriform and glomeruloid patterns, but rarely on ill-formed and fused 
glands.  The complex fused glands seem to be a borderline pattern of unknown 
prognostic significance on which a consensus could not be reached. 
 
Key words: Gleason grading; inter-observer variability; prostate cancer 
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INTRODUCTION 
The Gleason grading system is one of the most important predictors of prostate 
cancer progression. In 2005, the International Society of Urological Pathology (ISUP) 
organized a consensus conference on Gleason grading of prostate cancer.1 The goal of 
this meeting was to achieve consensus among leading genitourinary pathologists in 
specific areas of Gleason grading. At this meeting, large cribriform and ill-formed glands, 
classically described as Gleason grade 3, were re-defined as Gleason grade 4.1 
Subsequently, during the 2014 ISUP consensus conference on prostate cancer grading it 
was decided that small cribriform and glomeruloid glands should also be considered a 
Gleason grade 4 pattern.2 As a result, contemporary Gleason grade 4 prostate cancer 
represents a heterogeneous group of various growth patterns consisting of ill-formed, 
fused, cribriform and glomeruloid glands. While Gleason grade 4 is not sub-classified in 
daily clinical practice, recent studies have suggested that among Gleason grade 4 
growth patterns, cribriform growth is associated with a worse clinical outcome.3-6 
One of the major limitations of the Gleason grading system is its considerable 
inter-observer variability.7-19 Fused glands or small glands without lumina may, for 
instance, be interpreted as tangentially sectioned Gleason grade 3 or as a focal Gleason 
grade 4 prostate cancer.15 Despite this inter-observer variability, accurate identification 
of Gleason grade 4 prostate cancer is important for subsequent therapeutic decision-
making.7-19 For instance, patients with Gleason score 3+3=6 prostate cancer are often 
eligible for active surveillance, while patients with 3+4=7 are frequently excluded.20 To 
support future studies on Gleason grade 4 architectural sub-classification, it is 
important that individual growth patterns are well-defined and reproducible. We 
therefore undertook an inter-observer variability study among genitourinary 
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pathologists to assess the inter-observer agreement of individual Gleason grade 4 
growth patterns.  
 
MATERIALS AND METHODS 
Case selection 
Case selection (n=60) was undertaken by two investigators (C.K., G.v.L.) and 
included a representative collection of various Gleason grade 4 growth patterns.1 The 
selection aimed at including 10 Gleason grade 3, 40 Gleason grade 4 (10 per growth 
pattern) and 10 Gleason grade 5 cases, several of which deliberately showed ambiguous 
Gleason grade 4 patterns. In this study, we did not include ductal, intraductal or small 
cell prostate cancer. Digital images of hematoxylin and eosin–stained slides from 
selected prostate cancer cases were obtained using a NanoZoomer digital slide scanner 
(Hamamatsu Photonics K.K., Hamamatsu City, Japan). To ascertain that all participants 
evaluated the same tumour structures, tumour regions of interest were delineated in 
each case with a yellow line.  
Images were incorporated into a digital questionnaire. An international group of 
26 genitourinary pathologists was invited to participate in the study. Investigators 
involved in the case selection (C.K., G.v.L.) were not included in this group. Participants 
were asked to select a single predominant Gleason grade per case (3, 4, 5). If a case was 
assigned a Gleason grade 4, participants were asked to indicate a single  predominant 
growth pattern (ill-formed, fused, cribriform or glomeruloid). Participants had the 
opportunity to add comments by free-text. Finally, we collected basic demographic 
information from participants. No consensus training preceded the study. The 
questionnaire including all cases and instructions is shown in Supplemental Appendix 1.  
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Analysis 
Consensus was defined as at least 80% agreement on Gleason grade or Gleason 
grade 4 sub-classification. When 60% to 80% of the participants agreed, the 
classification was considered as “favoured”. The latter thresholds were chosen 
arbitrarily. Although participants were asked to select only one predominant grade 
and/or pattern per case, a combination of grades or patterns, e.g. “grade 3 & 4” or 
“fused & ill-formed”, was assigned in a few cases. We considered these combinations as 
separate categories in the analysis. This also applied to cases that were assigned by 
free-text as Gleason grade 2, which was not a selection option. In addition, some cases 
had been assigned “Gleason grade 3 cribriform” (n=4) or “Gleason grade 3 glomeruloid” 
(n=1). The latter cases were considered as Gleason grade 3 for the analysis. Their 
growth patterns, however, were included in Gleason grade 4 pattern analysis.  
 
RESULTS 
Participants 
Replies were received from 23 genitourinary pathologists (88% response rate) 
residing in 13 countries: United States (n=8), Canada (n=3), United Kingdom (n=2), 
Australia (n=1), Brazil (n=1) France (n=1), Germany (n=1), Italy (n=1), Singapore (n=1), 
Spain (n=1), Sweden (n=1), Switzerland (n=1), and New Zealand (n=1). Twenty 
participants were in academic practice (87%), 2 in private practice (8.7%), and 1 in 
academic, community and private practice (4%). The number of diagnostic prostate 
biopsies analysed per year was as follows: 100-250 (n=1; 4%), 250-500 (n=7; 30%), 
500-1000 (n=7; 30%), and more than 1000 (n=8; 35%).  
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Gleason grading 
Consensus on Gleason grade was reached in 47 (78%) cases: 8 had Gleason grade 
3, 35 Gleason grade 4, and 4 Gleason grade 5. In 9 cases (15%) a Gleason grade was 
favoured: 4 cases were favoured as Gleason grade 3, 1 Gleason grade 4, and 4 Gleason 
grade 5. In 4 cases (7%) there was less than 60% agreement on Gleason grading (Figure 
1). If less than 80% of participants agreed on Gleason grade, ill-formed (6/13, 46%) and 
fused (7/13, 54%) were the involved growth patterns . The frequencies of the Gleason 
grades and grade 4 patterns per case are listed in Supplemental table 1. 
 
Gleason grade 4 patterns 
The number of cases in which a pattern 4 was assigned by at least 1 pathologist 
was as follows: fused in n=41 (68%), cribriform n=30 (50%), ill-formed n=20 (33%) 
and glomeruloid n=13 (22%). Consensus on Gleason grade 4 pattern was reached in 13 
(37%) out of 35 consensus Gleason grade 4 cases, 7 of which were on cribriform (54%), 
5 on glomeruloid (38%), and 1 on fused (8%). None of the cases reached consensus for 
ill-formed glands.  
Among the 13 cases where at least 1 pathologist assigned a glomeruloid growth 
pattern, consensus on glomeruloid was present in 5 (38%) cases (Case 12, 18, 25, 29 
and 31). The glomeruloid pattern was favoured in 2 (15%) cases (Case 15 and 38); in 
both cases a considerable number of participants preferred cribriform, or a 
combination of both. Consensus on glomeruloid pattern was found in cases showing 
relatively small glomerulations, while the favoured cases all comprised large 
glomeruloid formations in which cribriform pattern was the preferred alternative 
(Figure 2).  
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Among the 30 cases where at least 1 participant assigned cribriform pattern, 
consensus on cribriform pattern was reached in 7 (23%) cases (Case 4, 9, 17, 27, 30, 43 
and 48), 2 of which (Case 4 and 48) reached 100% agreement. All 7 consensus cases had 
large cribriform glands with multiple punched-out lumina (Figure 3A-D). When 
cribriform pattern was favoured (n=2; 7%), fused glands were also considered by other 
participants in these cases (Case 16 and 59). Case 16 represented a relatively small 
gland containing several small mucin-filled spaces and delicate intervening stroma 
containing capillaries (Figure 3E). Case 59 showed a large glandular proliferation with 
elongated and round lumina and discrete fibro-vascular cores (Figure 3F).  
No consensus was reached on the ill-formed pattern in any of the cases, although 
this pattern was favoured in 5 (25%) (Case 2, 5, 7, 39 and 45; Figure 4). In all of these 
cases, the fused pattern was also considered by other participants. Consensus on the 
fused pattern was reached in only 1 (2%) case (Case 46), while the fused pattern was 
favoured in 4 (10%) (Case 19, 32, 54 and 57; Figure 5). In the latter cases, cribriform 
was also given by others. Here, the tumour glands had a complex architecture 
demonstrating anastomosing glands with elongated lumina and delicate intervening 
stroma and capillaries. 
There was less than 80% agreement on the pattern sub-classification in 22/35 
consensus Gleason grade 4 cases. In these cases, pattern disagreement occurred mostly 
on fused versus ill-formed and fused versus cribriform. Cases in which no agreement 
could be reached on fused or ill-formed pattern showed glands that were relatively 
small with an irregular border (Case 3 and 36; Figure 6 A-B). The other type of 
disagreement was characterized by complex epithelial anastomosing glands with 
delicate intervening fibro-vascular cores (“complex fused”), which were alternately 
assigned fused or cribriform pattern (Case 20, 23, 37, 40, 42 and 53, Figure 6C-H). The 
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distribution of the Gleason grade 4 patterns related to disagreement on Gleason grading 
or grade 4 sub-classification are summarized in Figure 7.  
 
DISCUSSION 
To facilitate future studies on Gleason grade 4 sub-classification, it is important 
that individual growth patterns are well-defined and reproducible. We therefore 
initiated an inter-observer study among genitourinary pathologists to assess the inter-
observer agreement of individual Gleason grade 4 growth patterns. We found that 
consensus on Gleason grade 4 growth pattern was predominantly reached on 
cribriform and glomeruloid, but hardly on ill-formed and fused glands. Although most 
participants agreed on classifying large epithelial proliferations with multiple punched-
out lumina lacking intervening stroma as the cribriform pattern, there was considerable 
inter-observer variation in the sub-classification of large complex epithelial 
proliferations with subtle intervening stroma; these were alternately regarded as 
cribriform or fused. To our knowledge, this histological category “complex fused” has 
not been described previously. Also, glomerulations with large intra-luminal cribriform 
proliferations were alternately regarded as cribriform or glomeruloid.  
Fused and ill-formed glands were the two patterns mostly related to Gleason 
grade variability (3, 4 or 5). Our findings are in line with two previous studies by 
Egevad et al. who looked at the inter-observer reproducibility of Gleason grade 4 
patterns among 15 and 337 pathologists respectively.21, 22 In one of these studies, the 
percentage of fused and ill-formed glands was inversely correlated with agreement 
among pathologists, while the cribriform pattern had no significant correlation with 
inter-observer variability.22 Zhou et al. recently suggested that adjacent tumour glands 
play an important role in decision-making in cases showing ambiguous ill-formed 
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patterns.19 They recommend that >10 poorly formed glands not immediately adjacent 
to other well-formed glands, should be considered ill-formed Gleason pattern 4. In 
contrast, poorly formed glands that are intermixed with well-formed glands, or ≤5 
poorly formed glands regardless of their location should be diagnostic features against 
Gleason pattern 4. Because our study specifically focused on growth pattern sub-
classification and lacked the presence of sufficient adjacent tumour glands, we were 
unable to make such observations. 
Although Gleason grading is subject to inter-observer variability, accurate 
identification of Gleason grade 4 prostate cancer is important for subsequent 
therapeutic decision-making.7-19 In many institutes, patients with Gleason score 6 
prostate cancer are candidates for active surveillance, while patients with Gleason score 
7 generally undergo therapeutic intervention.20 It has been estimated that up to 13% of 
patients would have been recommended different treatment solely based on pathologic 
re-evaluation of diagnostic biopsies.13, 18. Although the presence of a Gleason pattern 4 
is a clinical threshold for active treatment, Gleason grade 4 comprises a heterogeneous 
tumour group, covering at least 4 morphologically distinct patterns. Recent studies have 
suggested that individual Gleason grade 4 growth patterns are associated with clinical 
outcome.3-6 Dong et al. found in a consecutive series of 214 patients that the presence of 
cribriform growth was associated with a shorter time to biochemical recurrence and 
metastasis after radical prostatectomy, while fused and ill-formed glands were not.5 In a 
cohort of 161 Gleason score 7 prostate cancer patients, our group also found that the 
presence of cribriform growth was associated with a worse metastasis-free survival and 
disease-specific survival, while fused, glomeruloid and ill-formed glands were not.6 In a 
screen-detected cohort of 1031 men, we recently reported similar findings for 
cribriform growth in diagnostic biopsies.23 We therefore recommend reporting 
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presence of cribriform tumour glands in pathology reports, as this pattern appears to 
confer a less favourable outcome. 
 
The present study has several limitations. Cases were selected by two investigators, 
and intentionally included both classic and ambiguous cases. For instance, large 
epithelial proliferations with punched-out lumina and subtle scattered fibro-vascular 
cores, which are difficult to classify as either cribriform or fused, are relatively 
uncommon. It is therefore difficult to draw conclusions on the general agreement of 
Gleason grade 4 growth patterns in daily clinical practice. Secondly, participants were 
asked to score delineated tissue areas to ensure categorisation discordances were not 
due to evaluation of different tumour areas. However, the participants were therefore 
not able to interpret tumour growth patterns in a larger context. 
The present study did not make use of a statistical measure of agreement, such as 
Cohen’s κ or Krippendorff’s α.23, 24 Due to study design, in which a Gleason grade 4 sub-
classification only had to be indicated when Gleason grade 4 was present, we had 
missing values for grade 4 sub-classification when participants assigned a case a 
Gleason grade 3 or 5. Cohen’s κ was therefore not a suitable statistical measure in this 
context, as it is known to be highly influenced by missing values.25 Although Cohen’s κ is 
commonly used in the medical literature, its value, however, may not be sufficiently 
informative because it relates the proportion of observed agreement to variation in a 
sample (i.e. relative measure), while the clinician’s question of observer variation in 
individual cases calls for an absolute measure, i.e. percentage agreement.26  
In conclusion, consensus on Gleason grade 4 growth pattern was predominantly 
reached on glomeruloid and cribriform patterns, and rarely on ill-formed and fused 
patterns. These data indicate that Gleason grade 4 cribriform morphology, which has 
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been associated with a worse clinical outcome, is a reasonably reproducible pattern in 
Gleason grade 4 prostate cancer. The complex fused glands seem to be a borderline 
pattern of unknown prognostic significance on which a consensus could not be reached. 
 
LIST OF ONLINE SUPPORTING INFORMATION 
Supplemental Appendix 1. The questionnaire including all cases and instructions. 
 
Supplemental Table 1. The frequencies of the Gleason grades and grade 4 patterns per 
case 
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FIGURE LEGENDS 
 
Figure 1. Cases with less than 60% agreement on Gleason grade. A) Case 22. Grade 3 
n=11, grade 4 n=12 (fused n=12). B) Case 24. Grade 4 n=11, grade 5 n=11, grade 4 & 5 
n=1 (ill-formed n=7, fused n=2, cribriform n=1, fused & ill-formed n=2). C) Case 51. 
Grade 4 n=13, grade 5 n=8, grade 4 & 5 n=2 (fused n=1, ill-formed n=11, fused & ill-
formed n=2). D) Case 58. Grade 3 n=12, grade 4 n=11 (fused n=7, cribriform n=4, 
cribriform grade 3 n=1).  
 
Figure 2. Agreed (A, B) and favoured (C, D) cases with glomeruloid pattern. A) Case 18. 
Glomeruloid n=20, cribriform n=1, cribriform & glomeruloid n=1. B) Case 29. 
Glomeruloid n=19, cribriform n=3, fused n=1. C) Case 15. Glomeruloid n=16, cribriform 
n=5, cribriform & glomeruloid n=2. D) Case 38. Glomeruloid n=14, cribriform n=4, 
cribriform & glomeruloid n=5.  
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Figure 3. Agreed (A-D) and favoured (E, F) cases with cribriform pattern. A) Case 4. 
Cribriform n=23. B) Case 9. Cribriform n=21, fused n=2. C) Case 27. Cribriform n=20, 
glomeruloid n=2, cribriform grade 3 n=1. D) Case 48. Cribriform n=23. E) Case 16. 
Cribriform n=14, fused n=6, glomeruloid n=1, cribriform & glomeruloid n=1, cribriform 
& fused n=1. F) Case 59. Cribriform n=15, fused n=7, cribriform & fused n=1.  
 
Figure 4. Cases with favoured ill-formed pattern. A) Case 2. Ill-formed n=14, fused n=7, 
fused & ill-formed n=1. B) Case 5. Ill-formed n=18, fused n=2, fused & ill-formed n=1. C) 
Case 39. Ill-formed n=16, fused n=2, fused & ill-formed n=2. D) Case 45. Ill-formed 
n=18, fused n=3, fused & ill-formed n=1.  
 
Figure 5. Cases with favoured fused pattern. A) Case 19. Fused n=16, cribriform n=2, 
fused & ill-formed n=1. B) Case 32. Fused n=17, cribriform n=5, ill-formed n=1. C) Case 
54. Fused n=17, cribriform n=2, cribriform & fused n=1, cribriform & ill-formed n=1. D) 
Case 57. Fused n=14, cribriform n=4, ill-formed n=1, fused & ill-formed n=1, cribriform 
& fused n=1.  
 
Figure 6. Cases with less than 80% agreement on Gleason grade 4 sub-classification. A) 
Case 3. Ill-formed n=13, fused n=4, fused & ill-formed n=3. B) Case 36. Ill-formed n=13, 
fused n=4, fused & ill-formed=3. C) Case 23. Fused n=12, cribriform n=7, cribriform & 
fused n=2, fused & ill-formed n=1. D) Case 20. Fused n=13, cribriform n=6, cribriform & 
fused n=1, cribriform & fused & ill-formed =1. E) Case 37. Cribriform n=11, fused n=6, 
glomeruloid n=1, fused & glomeruloid n=1, cribriform & glomeruloid n=1, fused & ill-
formed & glomeruloid n=1. F) Case 40. Cribriform n=13, fused n=8, fused & ill-formed 
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n=1. G) Case 42. Cribriform n=13, fused n=7, cribriform & fused n=1. H) Case 53. Fused 
n=11, cribriform n=10, fused & ill-formed n=1, cribriform & ill-formed n=1.  
 
Figure 7. Schematic overview showing types of disagreement in cases with less than 
80% consensus on Gleason grading (n=13/60, blue arrows) and grade 4 sub-
classification (n=22/35, red arrows). The percentages represent the proportion of cases 
involved in a particular type of disagreement. The ellipse represents Gleason grade 3, 
the trapezium Gleason grade 5, and the rectangles Gleason grade 4 patterns. 
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